Impaired activation of platelets lacking protein kinase C-θ isoform

Blood

Volumn 113, Issue 11, 2009, Pages 2557-2567

  Nagy Jr , Bela ^a   Bhavaraju, Kamala ^a   Getz, Todd ^a   Bynagari, Yamini S ^a   Kim, Soochong ^a   Kunapuli, Satya P ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA2B BETA3 RECEPTOR; FERROUS CHLORIDE; GLYCOPROTEIN VI; MITOGEN ACTIVATED PROTEIN KINASE; PADGEM PROTEIN; PROTEIN KINASE C INHIBITOR; PROTEIN KINASE C THETA; PROTEINASE ACTIVATED RECEPTOR; PURINERGIC P2Y RECEPTOR; RECEPTOR; RECEPTOR FOR ACTIVATED C KINASE; SNARE PROTEIN; SYNTAXIN 4; THREONINE; THROMBOXANE A2; UNCLASSIFIED DRUG;

AGONIST; ANIMAL CELL; ANIMAL MODEL; ARTERY OCCLUSION; ARTICLE; CELL STIMULATION; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IN VIVO STUDY; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR BINDING; SECRETORY GRANULE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE RELEASE REACTION; THROMBOGENESIS; THROMBOSIS; WILD TYPE;

EID: 63849163448     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-07-169268     Document Type: Article

References (46)

1. Brass LF. More pieces of the platelet activation puzzle slide into place. J Clin Invest. 1999;104: 1663-1665.
2. Brass LF, Manning DR, Cichowski K, Abrams CS. Signaling through G proteins in platelets: to the integrins and beyond. Thromb Haemost. 1997;78:581-589.
3. Kappelmayer J, Nagy B Jr, Miszti-Blasius K, Hevessy Z, Setiadi H. The emerging value of P- selectin as a disease marker. Clin Chem Lab Med. 2004;42:475-486.
4. Gabbeta J, Yang X, Kowalska MA, Sun L, Dhanasekaran N, Rao AK. Platelet signal trans- duction defect with Galpha subunit dysfunction and diminished Galphaq in a patient with abnormal platelet responses. Proc Natl Acad Sci U S A. 1997;94:8750-8755.
5. Shattil SJ, Newman PJ. Integrins: dynamic scaffolds for adhesion and signaling in platelets. Blood. 2004;104:1606-1615.
6. Jackson SP, Nesbitt WS, Kulkarni S. Signaling events underlying thrombus formation. J Thromb Haemost. 2003;1:1602-1612.
7. Murugappan S, Tuluc F, Dorsam RT, Shankar H, Kunapuli SP. Differential role of protein kinase C delta isoform in agonist-induced dense granule secretion in human platelets. J Biol Chem. 2004;279:2360-2367.
8. Murugappan S, Shankar H, Bhamidipati S, Dorsam RT, Jin J, Kunapuli SP. Molecular mecha-nism and functional implications of thrombin-me- diated tyrosine phosphorylation of PKCdelta in platelets. Blood. 2005;106:550-557.
9. Harper MT, Poole AW. Isoform-specific functions of protein kinase C: the platelet paradigm. Bio- chem Soc Trans. 2007;35:1005-1008.
10. Mellor H, Parker PJ. The extended protein kinase C superfamily. Biochem J. 1998;332:281-292.
11. Newton AC. Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. Chem Rev. 2001;101:2353-2364.
12. Newton AC. Regulation of protein kinase C. Curr Opin Cell Biol. 1997;9:161-167.
13. Xu ZB, Chaudhary D, Olland S, et al. Catalytic domain crystal structure of protein kinase C-theta (PKCtheta). J Biol Chem. 2004;279:50401-50409.
14. Liu Y, Graham C, Li A, Fisher RJ, Shaw S. Phos- phorylation of the protein kinase C-theta activation loop and hydrophobic motif regulates its kinase activity, but only activation loop phos- phorylation is critical to in vivo nuclear-factor- kappaB induction. Biochem J. 2002;361:255-265.
15. Bakker W, Sipkema P, Stehouwer CD, et al. Protein kinase C theta activation induces insulin-mediated constriction of muscle resistance arteries. Diabetes. 2008;57:706-713.
16. Soriani A, Moran B, de Virgilio M, et al. Arole for PKCtheta in outside-in alpha(IIb)beta3 signaling. J Thromb Haemost. 2006;4:648-655.
17. Crosby D, Poole AW. Interaction of Bruton's ty- rosine kinase and protein kinase Ctheta in plate-lets: cross-talk between tyrosine and serine/thre- onine kinases. J Biol Chem. 2002;277:9958- 9965.
18. Covic L, Gresser AL, Kuliopulos A. Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets. Biochemistry.2000;39:5458-5467.
19. Lee SB, Rao AK, Lee KH, Yang X, Bae YS, Rhee SG. Decreased expression of phospholipase C- beta 2 isozyme in human platelets with impaired function. Blood. 1996;88:1684-1691.
20. Coughlin SR. Protease-activated receptors in vascular biology. Thromb Haemost. 2001;86:298-307.
21. Taniguchi M, Nagai K, Arao N, et al. YM-254890, a novel platelet aggregation inhibitor produced by Chromobacterium sp. QS3666. J Antibiot (Tokyo).2003;56:358-363.
22. Takasaki J, Saito T, Taniguchi M, et al. Anovel Galphaq/11-selective inhibitor. J Biol Chem.2004;279:47438-47445.
23. Chen L, Hahn H, Wu G, et al. Opposing cardio- protective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. Proc Natl Acad Sci U S A. 2001;98:11114-11119.
24. Cifuni SM, Wagner DD, Bergmeier W. CalDAG- GEFI and protein kinase C represent alternative pathways leading to activation of integrin alphaIIbbeta3 in platelets. Blood. 2008;112:1696-1703.
25. Akkerman JW, Gorter G, Kloprogge E. Kinetic analysis of alpha-granule secretion by platelets: a methodological report. Thromb Res. 1982;27:59-64.
26. Yoshioka A, Shirakawa R, Nishioka H, et al. Identification of protein kinase Calpha as an essential, but not sufficient, cytosolic factor for Ca2+-in- duced alpha- and dense-core granule secretion in platelets. J Biol Chem. 2001;276:39379-39385.
27. Yacoub D, Theoret JF, Villeneuve L, et al. Essential role of protein kinase C delta in platelet signaling, alpha IIb beta 3 activation, and thromboxane A2 release. J Biol Chem. 2006;281:30024-30035.
28. Libersan D, Merhi Y. Platelet P-selectin expression: requirement for protein kinase C, but not protein tyrosine kinase or phosphoinositide 3-ki- nase. Thromb Haemost. 2003;89:1016-1023.
29. Chung SH, Polgar J, Reed GL. Protein kinase C phosphorylation of syntaxin 4 in thrombin-acti- vated human platelets. J Biol Chem. 2000;275: 25286-25291.
30. Nakamura T, Jamieson GA, Okuma M, Kambayashi J, Tandon NN. Platelet adhesion to native type I collagen fibrils: role of GPVI in divalent cation-dependent and -independent adhesion and thromboxane A2 generation. J Biol Chem. 1998;273:4338-4344.
31. Henriksen RA, Samokhin GP, Tracy PB. Throm- bin-induced thromboxane synthesis by human platelets: properties of anion binding exosite I- independent receptor. Arterioscler Thromb Vasc Biol. 1997;17:3519-3526.
32. Henriksen RA, Hanks VK. PAR-4 agonist AY- PGKF stimulates thromboxane production by human platelets. Arterioscler Thromb Vasc Biol.2002;22:861-866.
33. Arita H, NakanoT, Hanasaki K. Thromboxane A2: its generation and role in platelet activation. Prog Lipid Res. 1989;28:273-301.
34. Roger S, Pawlowski M, Habib A, Jandrot-Perrus M, Rosa JP, Bryckaert M. Costimulation of the Gi-coupled ADP receptor and the Gq-coupled TXA2 receptor is required for ERK2 activation in collagen-induced platelet aggregation. FEBS Lett. 2004;556:227-235.
35. Nadal-Wollbold F, Pawlowski M, Levy-Toledano S, Berrou E, Rosa JP, Bryckaert M. Platelet ERK2 activation by thrombin is dependent on calcium and conventional protein kinases C but not Raf-1 or B-Raf. FEBS Lett. 2002;531:475-482.
36. Borsch-Haubold AG. Regulation of cytosolic phospholipase A2 by phosphorylation. Biochem Soc Trans. 1998;26:350-354.
37. Fabre JE, Nguyen M, Latour A, et al. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat Med. 1999;5:1199-1202.
38. Flaumenhaft R, Croce K, Chen E, Furie B, Furie BC. Proteins of the exocytotic core complex mediate platelet alpha-granule secretion: roles of vesicle-associated membrane protein, SNAP-23, and syntaxin 4. J Biol Chem. 1999;274:2492- 2501.
39. Lemons PP, Chen D, Whiteheart SW. Molecular mechanisms of platelet exocytosis: requirements for alpha-granule release. Biochem Biophys Res Commun. 2000;267:875-880.
40. Quinton TM, Ozdener F, Dangelmaier C, Daniel JL, Kunapuli SP. Glycoprotein VI-mediated plate-let fibrinogen receptor activation occurs through calcium-sensitive and PKC-sensitive pathways without a requirement for secreted ADP. Blood. 2002;99:3228-3234.
41. 42.Quinton TM, Kim S, Dangelmaier C, et al. Protein kinase C- and calcium-regulated pathways independently synergize with Gi pathways in agonist- induced fibrinogen receptor activation. Biochem J. 2002;368:535-543.
42. Buensuceso CS, Obergfell A, Soriani A, et al. Regulation of outside-in signaling in platelets by integrin-associated protein kinase C beta. J Biol Chem. 2005;280:644-653.
43. Woulfe D, Jiang H, Morgans A, Monks R, Birnbaum M, Brass LF. Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2. J Clin Invest. 2004;113:441-450.
44. Sun L, Mao G, Rao AK. Association of CBFA2 mutation with decreased platelet PKC-theta and impaired receptor-mediated activation of GPIIb- IIIa and pleckstrin phosphorylation: proteins regulated by CBFA2 play a role in GPIIb-IIIa activation. Blood. 2004;103:948-954.
45. Garcia A, Quinton TM, Dorsam RT, Kunapuli SP. Src family kinase-mediated and Erk-mediated thromboxane A2 generation are essential for VWF/GPIb-induced fibrinogen receptor activation in human platelets. Blood. 2005;106:3410-3414.
46. Garcia A, Shankar H, Murugappan S, Kim S, Kunapuli SP. Regulation and functional consequences of ADP receptor-mediated Erk2 activation in platelets. Biochem J. 2007;404:299-308.